Rubrik, Inc. (NYSE:RBRK – Get Free Report) Director Ravi Mhatre sold 15,933 shares of the business’s stock in a transaction on Friday, September 13th. The stock was sold at an average price of $30.19, for a total transaction of $481,017.27. The transaction was disclosed in a document filed with the SEC, which is available through this link.
Rubrik Stock Performance
Rubrik stock traded up $0.86 during midday trading on Tuesday, reaching $32.24. The stock had a trading volume of 3,433,764 shares, compared to its average volume of 1,273,353. Rubrik, Inc. has a twelve month low of $28.34 and a twelve month high of $40.00. The firm has a fifty day moving average of $33.53.
Institutional Trading of Rubrik
Hedge funds and other institutional investors have recently modified their holdings of the business. Register Financial Advisors LLC purchased a new stake in shares of Rubrik in the second quarter worth approximately $227,000. Sei Investments Co. acquired a new position in Rubrik in the 2nd quarter valued at approximately $235,000. PFG Investments LLC purchased a new stake in Rubrik in the 2nd quarter worth approximately $242,000. Natixis Advisors LLC purchased a new position in shares of Rubrik during the 2nd quarter valued at $406,000. Finally, Bank of Montreal Can purchased a new stake in shares of Rubrik during the second quarter worth $427,000.
Analysts Set New Price Targets
View Our Latest Stock Analysis on RBRK
Rubrik Company Profile
Rubrik, Inc provides data security solutions to individuals and businesses worldwide. The company offers enterprise data protection, unstructured data protection, cloud data protection, and SaaS data protection solutions; data threat analytics; data security posture; and cyber recovery solutions. It serves financial, retail, trade, transportation, energy, industrial, healthcare and life science, education, technology, media, communications, and public sectors.
Featured Stories
- Five stocks we like better than Rubrik
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- Stock Analyst Ratings and Canadian Analyst Ratings
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- Why Are These Companies Considered Blue Chips?
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Rubrik Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rubrik and related companies with MarketBeat.com's FREE daily email newsletter.